wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51740588-88B8D264-FCF5-45D4-9437-79A0D2A8B37B
Q51740588-88B8D264-FCF5-45D4-9437-79A0D2A8B37B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51740588-88B8D264-FCF5-45D4-9437-79A0D2A8B37B
The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis.
P2860
Q51740588-88B8D264-FCF5-45D4-9437-79A0D2A8B37B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51740588-88B8D264-FCF5-45D4-9437-79A0D2A8B37B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6a2c4e677c5cd5d546e1fcc53635e9befd9b70f4
P2860
Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis.